Abstract
Baculovirus is an effective vector for gene delivery into various mammalian cells, including chondrocytes and mesenchymal stem cells, and has been employed for diverse applications. By gene delivery and expression of the growth factor, recombinant baculovirus has been shown to modulate the differentiation state of the cells and stimulates the production of extracellular matrix and tissue formation, hence repairing the damaged cartilage and bone in vivo. This article reviews the studies pertaining to the applications of baculovirus-mediated gene delivery in cartilage and bone tissue engineering and discusses recent progress, future applications and potential hurdles.
Keywords: Baculovirus, bone, cartilage, gene therapy, tissue engineering
Current Gene Therapy
Title: Baculovirus as a Gene Delivery Vector for Cartilage and Bone Tissue Engineering
Volume: 10 Issue: 3
Author(s): Chin-Yu Lin, Chia-Hsin Lu, Wen-Yi Luo, Yu-Han Chang, Li-Yu Sung, Hsin-Yi Chiu and Yu-Chen Hu
Affiliation:
Keywords: Baculovirus, bone, cartilage, gene therapy, tissue engineering
Abstract: Baculovirus is an effective vector for gene delivery into various mammalian cells, including chondrocytes and mesenchymal stem cells, and has been employed for diverse applications. By gene delivery and expression of the growth factor, recombinant baculovirus has been shown to modulate the differentiation state of the cells and stimulates the production of extracellular matrix and tissue formation, hence repairing the damaged cartilage and bone in vivo. This article reviews the studies pertaining to the applications of baculovirus-mediated gene delivery in cartilage and bone tissue engineering and discusses recent progress, future applications and potential hurdles.
Export Options
About this article
Cite this article as:
Lin Chin-Yu, Lu Chia-Hsin, Luo Wen-Yi, Chang Yu-Han, Sung Li-Yu, Chiu Hsin-Yi and Hu Yu-Chen, Baculovirus as a Gene Delivery Vector for Cartilage and Bone Tissue Engineering, Current Gene Therapy 2010; 10 (3) . https://dx.doi.org/10.2174/156652310791321242
DOI https://dx.doi.org/10.2174/156652310791321242 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Extracellular Matrix of Blood Vessels
Current Pharmaceutical Design In Vitro Blood-Brain Barrier Models – Latest Advances and Therapeutic Applications in a Chronological Perspective
Mini-Reviews in Medicinal Chemistry Ex Vivo Modification of Cells to Induce a Muscle-Based Expression
Current Gene Therapy Management of the Low Cardiac Output Syndrome Following Surgery for Congenital Heart Disease
Current Cardiology Reviews Apis mellifera Proteomics: Where Will the Future Bee?
Current Proteomics Conserved Molecular Players for Axon Guidance and Angiogenesis
Current Protein & Peptide Science Persistent Pulmonary Hypertension of the Newborn: Physiology, Hemodynamic Assessment and Novel Therapies
Current Pediatric Reviews Adult Stem Cell Transplants for Spinal Cord Injury Repair: Current State in Preclinical Research
Current Stem Cell Research & Therapy Cardiovascular Complications in Patients with Klinefelter’s Syndrome
Current Pharmaceutical Design Tetralogy of Fallot and Hypoplastic Left Heart Syndrome – Complex Clinical Phenotypes Meet Complex Genetic Networks
Current Genomics Stem Cell Therapy for Ischaemic Stroke: Translation from Preclinical Studies to Clinical Treatment
CNS & Neurological Disorders - Drug Targets Nonviral Vectors for Cancer Gene Therapy: Prospects for Integrating Vectors and Combination Therapies
Current Gene Therapy Smoking and Congenital Heart Disease: The Epidemiological and Biological Link
Current Pharmaceutical Design Eisenmenger Syndrome: Recent Advances in Pharmacotherapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Baculovirus Expression Vectors for Insect and Mammalian Cells
Current Drug Targets Neuromodulation of the Perinatal Respiratory Network
Current Neuropharmacology Congenital Heart Disease: The Crossroads of Genetics, Epigenetics and Environment
Current Genomics The Adult Patient with Eisenmenger Syndrome: A Medical Update After Dana Point Part I: Epidemiology, Clinical Aspects and Diagnostic Options
Current Cardiology Reviews Troponin in Newborns and Pediatric Patients
Cardiovascular & Hematological Agents in Medicinal Chemistry Potential Replication of Induced Pluripotent Stem Cells for Craniofacial Reconstruction
Current Stem Cell Research & Therapy